FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in 
primary breast cancer

Thussbas, C.; Nahrig, J.; Streit, S.; Bange, J.; Kriner, M.; Kates, R.; Ulm, K.; Kiechle, M.; Hoefler, H.; Ullrich, A.; Harbeck, N.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer

MPS-Authors

/persons/resource/persons78812

Ullrich, A.
Ullrich, Axel / Molecular Biology, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Thussbas, C., Nahrig, J., Streit, S., Bange, J., Kriner, M., Kates, R., et al. (2006). FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. Journal of Clinical Oncology, 24(23), 3747-3755.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0010-6276-4

Abstract

There is no abstract available